title: Synthetic Fusion Protein CAR Technology to Redirect T Cell Antigen Specificity to Promote Organ Transplant Tolerance.
authors.affiliation: Centre de Recherche en Transplantation et Immunologie UMR1064, INSERM, Université de Nantes, Nantes, France.|Institut de Transplantation Urologie Néphrologie (ITUN), CHU Nantes, Nantes, France.|CIC Biotherapy, CHU Nantes, Nantes, France.|LaxEx Transplantex, Strasbourg, France.
authors.forename: S
authors.initials: S
authors.lastname: Brouard
authors.affiliation: LaxEx Transplantex, Strasbourg, France.|Alloimmunité-Autoimmunité-Transplantation UMR1160, INSERM, Hôpital Saint Louis, Paris, France.|Université Paris Diderot-Sorbonne Paris Cité, Paris, France.
authors.forename: N
authors.initials: N
authors.lastname: Mooney
mesh_terms: D006084:Graft Rejection; D006801:Humans; D000076962:Receptors, Chimeric Antigen; D050378:T-Lymphocytes, Regulatory; D014019:Tissue Donors; D023001:Transplantation Tolerance
chemical_list: D000076962:Receptors, Chimeric Antigen
keywords: basic (laboratory) research/science; editorial/personal viewpoint; fusion proteins and monoclonal antibodies: T cell specific; gene therapy; graft survival; immune regulation; immunobiology; immunosuppressant; immunosuppression/immune modulation; kidney transplantation/nephrology; tolerance